Department of Error
- PMID: 34364522
- DOI: 10.1016/S0140-6736(21)01745-1
Department of Error
Erratum for
-
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.Lancet. 2021 Feb 6;397(10273):499-509. doi: 10.1016/S0140-6736(21)00219-1. Lancet. 2021. PMID: 33549194 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources